ArticleResults in physics2021
COVID-19 Vaccine: A neutrosophic MCDM approach for determining the priority groups.
Article in Results in physics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Does COVID-19 vaccination affect risk perception and adherence to preventive behaviors? A systematic review and meta-analysis.Frontiers in public health · 2025Pooled it
- A multi-phase, multi-method assessment of national COVID-19 vaccination performance with equity analysis.Scientific reports · 2026Article
- A novel mathematical model for prioritization of individuals to receive vaccine considering governmental health protocols.The European journal of health economics : HEPAC : health economics in prevention and care · 2023Article
- A Fuzzy Hybrid MCDM Approach for Assessing the Emergency Department Performance during the COVID-19 Outbreak.International journal of environmental research and public health · 2023Article
- COVID-19 and Rumors: A Dynamic Nested Optimal Control Model.Pattern recognition · 2023Article
- Systematic review of MCDM approach applied to the medical case studies of COVID-19: trends, bibliographic analysis, challenges, motivations, recommendations, and future directions.Complex & intelligent systems · 2023Article
- An extended picture fuzzy multicriteria group decision analysis with different weights: A case study of COVID-19 vaccine allocation.Socio-economic planning sciences · 2023Article
- A Multi-Criteria Decision-Making Model with Interval-Valued Intuitionistic Fuzzy Sets for Evaluating Digital Technology Strategies in COVID-19 Pandemic Under Uncertainty.Arabian journal for science and engineering · 2023Article
- Article
- Multi-criteria decision making of COVID-19 vaccines (in India) based on ranking interpreter technique under single valued bipolar neutrosophic environment.Expert systems with applications · 2022Article
- The applications of MCDM methods in COVID-19 pandemic: A state of the art review.Applied soft computing · 2022Review
- New multi-criteria decision-making technique based on neutrosophic axiomatic design.Scientific reports · 2022Article
- Rise of multiattribute decision-making in combating COVID-19: A systematic review of the state-of-the-art literature.International journal of intelligent systems · 2022Article
- Strategies and safety considerations of booster vaccination in COVID-19.Bosnian journal of basic medical sciences · 2022Review
- COVID-19 and Chikungunya: an optimal control model with consideration of social and environmental factors.Journal of ambient intelligence and humanized computing · 2022Article
- Anti-SARS-CoV-2 Antibody Responses 5 Months Post Complete Vaccination of Moroccan Healthcare Workers.Vaccines · 2022Article
- The impact of vaccination on the spread of COVID-19: Studying by a mathematical model.Physica A · 2022Article
- Novel dynamic fuzzy Decision-Making framework for COVID-19 vaccine dose recipients.Journal of advanced research · 2022Article
- Multi-criteria decision-making for coronavirus disease 2019 applications: a theoretical analysis review.Artificial intelligence review · 2022Article
- Healthcare's Sustainable Resource Planning Using Neutrosophic Goal Programming.Journal of healthcare engineering · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Since the outbreak of COVID-19, most of the countries around the world have been confronting the loss of lives, struggling with several economical parameters, i.e. low GDP growth, increasing unemployment rate, and others. It's been 11 months since we are struggling with COVID-19 and some of the countries already facing the second wave of COVID-19. To get rid of these problems, inventions of a vaccine and its optimum distribution is a key factor. Many companies are trying to find a vaccine, but for nearly 8 billion people it would be impossible to find a vaccine. Thus, the competition arises, and this competition would be too intense to satisfy all the people of a country with the vaccine. Therefore, at first, governments must identify priority groups for allocating COVID-19 vaccine doses. In this work, we identify four main criteria and fifteen sub-criteria based on age, health status, a woman's status, and the kind of job. The main and sub-criteria will be evaluated using a neutrosophic Analytic Hierarchy Process (AHP). Then, the COVID-19 vaccine alternatives will be ranked using a neutrosophic TOPSIS method. All the results obtained indicate that the healthcare personnel, people with high-risk health, elderly people, essential workers, pregnant and lactating mothers are the most prioritized people to take the vaccine dose first. Also, the results indicate that the most appropriate vaccine for patients and health workers have priority over other alternative vaccines.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.